Brief: Argenx Announces FDA Approval Of Vyvgart Hytrulo Prefilled Syringe For Self-Injection In Generalized Myasthenia Gravis And Chronic Inflammatory Demyelinating Polyneuropathy
10/04/2025 22:52
April 10 (Reuters) - argenx SE ARGX.BR: ARGENX ANNOUNCES FDA APPROVAL OF VYVGART HYTRULO PREFILLED SYRINGE FOR SELF-INJECTION IN GENERALIZED MYASTHENIA GRAVIS AND CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY Source text: ID:nGNX9nvb89 Further company coverage: ARGX.BR ((Reuters.Briefs@thomsonreuters.com;))